The
CBS Evening News (1/29, story
9, 1:45, Pelley, 5.58M) reported that new research suggests “a link between
testosterone supplements and heart attacks.”
USA Today (1/30, Szabo, 5.82M)
reports that the study, published in PLOS One, found that “taking testosterone
therapy doubled the risk of heart attack among men over age 65 and nearly
tripled the risk in younger men with a history of heart disease.” This
research, “which involved 56,000 men, is the latest in a series of studies
raising concerns about the heart attack risk from testosterone therapy, whose
popularity has ballooned in recent years.”
On
its website, NBC News (1/30,
Fox, 6.79M) reports that “to be sure,” the researchers “compared the men
getting testosterone to those getting prescriptions for erectile dysfunction
drugs, as the two groups are similar in many ways.” The investigators found
that the ED medications “only very slightly raised the risk of heart attack.”
The
New York Times (1/30,
O'Connor, 9.61M) “Well” blog reports, “By itself, the new study, which was not
a randomized trial...’may not tell us very much,’ said Dr. Michael Lauer, the
director of cardiovascular sciences at the National Heart, Lung and Blood
Institute, who was not involved in the study.” However, added Dr. Lauer, “when
you put this together with the rest of the medical literature, this tells us
that we potentially have a problem.” Meanwhile, “in a statement, Andrea
Fischer, an F.D.A. spokeswoman, said the agency was reviewing the new
findings.”
On
its website, TIME (1/30,
Sifferlin, 21.77M) reports that although it is unclear “why testosterone can
harm the heart, some studies suggest that it can lower levels of HDL, or good
cholesterol, and therefore increase the risk of heart disease.”
Meanwhile,
on the CBS News (1/30, 3.87M)
website, CBS’ Dr. Jon Lapook writes that a “possible way testosterone might be
causing problems is by increasing clotting within arteries supplying the
heart.”
Forbes (1/30, 6.03M)
contributor Ed Silverman points out that these “findings come amid years of aggressive
promotion of testosterone treatments.” Research “published last fall in the
Journal of the American Medical Association noted that annual prescriptions for
these elixirs rose more than five-fold from 2000 to 2011, reaching 5.3 million
prescriptions.” The Los Angeles Times
(1/30, Healy, 3.07M) “Science Now” blog also covers the story.
Posted
by: Steven Almany M.D.
No comments:
Post a Comment